CD47 in Erythrocyte Ageing and Clearance - the Dutch Point of View

Patrick Burger1, Dirk de Korte, Timo K van den Berg

  • 1Sanquin Research and Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, the Netherlands.

Insights

CD47, a

Area of Science:

  • Immunology and Cell Biology
  • Hematology

Background:

  • CD47 acts as a 'don't eat me' signal, inhibiting phagocytosis.
  • Aged erythrocytes are typically cleared via CD47-mediated signaling.
  • Recent findings suggest CD47 can switch to an 'eat me' signal.

Purpose of the Study:

  • To review molecular mechanisms of CD47 conformational change.
  • To discuss signal transduction in CD47-mediated erythrocyte phagocytosis.
  • To address consequences for aged erythrocyte clearance and transfusion.

Main Methods:

  • Review of experimental data and literature.
  • Analysis of molecular pathways involved in CD47 signaling.
  • Discussion of cellular mechanisms of phagocytosis.

Main Results:

  • CD47 can undergo a conformational change, converting its signal from 'don't eat me' to 'eat me'.
  • This switch appears to involve the same receptor, SIRPα, which normally inhibits phagocytosis.
  • This mechanism impacts aged erythrocyte clearance and post-transfusion outcomes.

Conclusions:

  • The CD47 'eat me' signal switch is a novel mechanism for erythrocyte clearance.
  • Understanding this pathway is crucial for managing erythrocyte turnover and transfusion efficacy.
  • Further research into CD47 modulation could offer therapeutic strategies.

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.